Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Validea
|
$12.00
|
|
Provider: Datamonitor
|
$175.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Roche Holding AG Revamps Research Operations, Cuts 1,000 U.S. Jobs-Reuters
Reuters reported that Roche Holding AG said it was overhauling its research operations by closing the 80-year-old New Jersey facility where Valium was discovered, cutting 1,000 jobs and replacing its drug research chief. Roche will also shutter its 127-acre (51.4 hectares) Nutley, N.J.-based campus and move those activities to Germany and Switzerland, a consolidation aimed at curbing drug development costs. The sites in Switzerland and Germany are expected to add about 80 jobs, the Company said.
Latest Developments for Roche Holding AG
Latest Key Developments in Pharmaceuticals
- Biogen Idec Inc And Swedish Orphan Biovitrum AB Presents New Data From Phase 3 Study Of Long-Lasting Hemophilia Factor Candidate ALPROLIX
- Medicines Co Announces Positive Results For Solo II Trial Of Oritavancin In Treatment Of Acute Bacterial Skin And Skin Structure Infections
- OHKI CO LTD Announces Concern of Uncollectible or Delayed Receivables
- CKD Bio Announces Resignation of Co-CEO
- Share this
- Link this
- Digg this


Follow Reuters